0001829802 2026-06-18 2026-06-18 0001829802 1 2026-06-18 2026-06-18 0001829802 2 2026-06-18 2026-06-18 0001829802 3 2026-06-18 2026-06-18 0001829802 4 2026-06-18 2026-06-18 0001829802 5 2026-06-18 2026-06-18 iso4217:USD pure S-3 S-3ASR EX-FILING FEES 0001829802 Faeth Therapeutics, Inc. N/A N/A S-3 Faeth Therapeutics, Inc. false Equity Common Stock, $0.0001 par value per share true 0.0001381 0.00 false Equity Preferred Stock, $0.0001 par value per share true 0.0001381 0.00 false Debt Debt Securities true 0.0001381 0.00 false Other Warrants true 0.0001381 0.00 false Equity Common Stock, $0.0001 par value per share true 150000000.00 0.0001381 20715.00 150000000.00 20715.00 0.00 0.00 20715.00 The registrant is registering hereby an unspecified principal amount or number and offering price of securities of each identified class as may be offered, from time to time, hereunder, along with an indeterminate principal amount or number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Separate consideration may or may not be received for securities that are issued upon conversion, exercise or exchange of other securities. The proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D of Form S-3 under the Securities Act. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. In accordance with Rule 456(b) and 457(r) under the Securities Act, the registrant is deferring payment of all registration fees other than the registration fee due in connection with $150,000,000 of shares of common stock that may be issued and sold from time to time under the sale agreement prospectus contained in this registration statement. Any subsequent registration fees will be paid on a pay-as-you-go basis. See Offering Note 1. See Offering Note 1. See Offering Note 1. The registration fee is calculated in accordance with Rule 457(o) under the Securities Act, base on the proposed maximum aggregate offering price.